BEVESPI AEROSPHERE 4.8 ug/1
Glycopyrrolate and formoterol fumarate · AEROSOL, METERED · AstraZeneca Pharmaceuticals LP
BEVESPI AEROSPHERE is a aerosol, metered containing glycopyrrolate and formoterol fumarate at 4.8 ug/1, taken respiratory (inhalation). Manufactured by AstraZeneca Pharmaceuticals LP.
Key Facts
- Brand Name
- BEVESPI AEROSPHERE
- Generic Name
- Glycopyrrolate and formoterol fumarate
- NDC Code (Product)
0310-4600- Manufacturer
- AstraZeneca Pharmaceuticals LP
- Strength
- 4.8 ug/1
- Dosage Form
- AEROSOL, METERED
- Route
- RESPIRATORY (INHALATION)
- Marketing Status
- Application #
- NDA208294
- Marketing Start
- 10/03/2016
Recall History
Cardinal Health Inc.
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Frequently Asked Questions
What is BEVESPI AEROSPHERE used for?
BEVESPI AEROSPHERE contains Glycopyrrolate and formoterol fumarate. It is a aerosol, metered taken respiratory (inhalation). Consult your doctor for specific uses.
Is BEVESPI AEROSPHERE a controlled substance?
BEVESPI AEROSPHERE is not classified as a controlled substance by the DEA.
What is the generic name for BEVESPI AEROSPHERE?
The generic name for BEVESPI AEROSPHERE is Glycopyrrolate and formoterol fumarate. There are no other listed brand versions of Glycopyrrolate and formoterol fumarate.
What is the NDC code for BEVESPI AEROSPHERE 4.8 ug/1?
The NDC (National Drug Code) for BEVESPI AEROSPHERE 4.8 ug/1 is 0310-4600, listed by AstraZeneca Pharmaceuticals LP.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)